CMV

Letermovir for CMV Prevention After Lung Transplantation

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy

Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Expansion of Virus-Specific Lymphocytes for Cell Therapy